EUVIMEDEUVIMED entdecken
Crossref

Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal

Sema Koc Yildirim, Ece Erbagci, Neslihan Demirel Ogut, Simge Unal, Ece Gokyayla

Allergy and Asthma Proceedings · 01.01.2026 · 47 (1) · 32-39

DOI: 10.2500/aap.2026.47.250089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy and Asthma Proceedings, erschienen am 01.01.2026. Verfasst von Sema Koc Yildirim und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology and Venereology, Usak University Faculty of Medicine, Usak, Turkey and. Hauptthemen laut MEDLINE: Omalizumab, Chronic Urticaria, Anti-Allergic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is currently no accepted biomarker for predicting which patients will experience relapse after discontinuation of omalizumab therapy.

Objective

This retrospective study aimed to identify clinical and laboratory markers associated with chronic spontaneous urticaria relapse. Methods: “Relapse” was defined as a urticaria control test score of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmalizumabChronic UrticariaAnti-Allergic AgentsHumansFemaleRecurrenceMaleRetrospective StudiesAdultBiomarkersAutoimmunityImmunoglobulin EMiddle AgedC-Reactive ProteinTreatment InterruptionAutoantibodies

Substanzen

OmalizumabBiomarkersImmunoglobulin EAnti-Allergic AgentsC-Reactive ProteinAutoantibodies

Autor:innen und Institutionen

  • From the Department of Dermatology and Venereology, Usak University Faculty of Medicine, Usak, Turkey and.
  • Department of Dermatology and Venereology, Usak Training and Research Hospital, Usak, Turkey.

Zitieren

APA

Koc Yildirim, S., Erbagci, E., Demirel Ogut, N., Unal, S., & Gokyayla, E. (2026). Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal. Allergy and Asthma Proceedings, 47(1), 32-39. https://doi.org/10.2500/aap.2026.47.250089

Vancouver

Koc Yildirim S, Erbagci E, Demirel Ogut N, Unal S, Gokyayla E. Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal. Allergy and Asthma Proceedings. 2026;47(1):32-39. doi:10.2500/aap.2026.47.250089

BibTeX
@article{KocYildirim2026,
  author = {Koc Yildirim, Sema and Erbagci, Ece and Demirel Ogut, Neslihan and Unal, Simge and Gokyayla, Ece},
  title = {Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal},
  journal = {Allergy and Asthma Proceedings},
  year = {2026},
  volume = {47},
  number = {1},
  pages = {32--39},
  doi = {10.2500/aap.2026.47.250089}
}
Kostenlos starten →